PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Alto Marketing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Biocompatibles Launch CelLuminate™ Intracellular Delivery System - Prize draw open to EMBO delegates and online registrants
Biocompatibles Launch CelLuminate™ Intracellular Delivery System

 

NewswireToday - /newswire/ - Farnham, Surrey, United Kingdom, 2009/08/25 - Prize draw open to EMBO delegates and online registrants.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

UK company Biocompatibles is launching a new product in its CelLuminate™ range of intracellular delivery systems, at EMBO 2009 in Amsterdam on the 29th August – 1st September. The new CelLuminate™ VPS (Vesicle-forming Polymer System) improves the efficiency of intracellular delivery of bioactive molecules compared to conventional liposomal systems. It can deliver anything from fluorophores to RNA, DNA and proteins – efficiently and with minimal cytotoxic effects. To celebrate the launch, Biocompatibles (biocompatibles.com) is giving away 10 samples of CelLuminate VPS (worth £200 each) in a prize draw. To enter the draw, researchers will need to visit Biocompatibles on Stand 29 at EMBO. Those not attending the conference can enter the draw by clicking the online link below. The draw closes at 4pm on Monday 14th September 2009.

CelLuminate is made from proprietary biomimetic copolymer and exploits the natural cellular endocytotic pathways. As the surface chemistry of the vesicles mimics that of cell membranes, the rate and amount of vesicles endocytosed is orders of magnitude higher than conventional liposomal systems. Being pH-sensitive, the CelLuminate vesicles utilise the pH drop in the endosome to deliver the desired payload into the cell cytosol. CelLuminate VPS is designed so that researchers can prepare their own vesicles to encapsulate any bioactive agent, easily and without experience.

CelLuminate VPS (celluminate.com), has been developed following requests from researchers using the CelLuminate Red rhodamine-loaded cell staining system, which was launched earlier this year. CelLuminate Red has enabled improved cell fluorescence studies, as cells can live for up to two weeks and fluorescence lasts longer. “We know that researchers find that CelLuminate is easy to use and practical” said Tim Maloney, Biocompatibles’ Marketing Director. “Speaking with researchers who were using CelLuminate Red, it was clear that many also wanted to use the CelLuminate vesicle delivery system to deliver their own fluorescent probes, and other bioactive molecules – which led to the development of CelLuminate VPS. As we are still exploring the potential of the system, we wanted to offer researchers the opportunity to trial CelLuminate VPS at no cost, and the ideal way to do this was in a prize draw.

For more information and to enter the prize draw please visit our site or see Biocompatibles on Stand A29 at EMBO 2009.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Alto Marketing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Biocompatibles Launch CelLuminate™ Intracellular Delivery System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Leigh Dilley 
+44 1489 557672 clarer[.]alto-marketing.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Alto Marketing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)